Development of factor VIIa inhibitors as novel anticoagulants.

被引：0
|
作者：
Kolesnikov, A [1 ]
Rai, R [1 ]
Young, WB [1 ]
Torkelson, S [1 ]
Shrader, WD [1 ]
Leahy, EM [1 ]
Katz, BA [1 ]
Sprengeler, PA [1 ]
Liu, L [1 ]
Mordenti, J [1 ]
机构：
[1] Celera, San Francisco, CA 94080 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 227卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
351-MEDI
引用
收藏
页码：U71 / U71
页数：1
相关论文
共 50 条
  • [31] Screening of a Library for Factor VIIa Inhibitors
    Bridoux, Alexandre
    Mousal, Shaker A.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (06) : 481 - 489
  • [32] Atropisomerism in macrocyclic factor VIIa inhibitors
    Glunz, Peter
    Wurtz, Nicholas
    Zhang, Xiaojun
    Mueller, Luciano
    Cheney, Daniel
    Wei, Anzhi
    Wong, Pancras
    Wexler, Ruth
    Priestley, Eldon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [33] New anticoagulants in 2024: Development of factor XI and XIa inhibitors
    Bentounes, Nun K.
    Melicine, Sophie
    Martin, Anne Celine
    Smadj, David M.
    Gendron, Nicolas
    HEMATOLOGIE, 2024, 30 (03): : 191 - 206
  • [34] Direct oral anticoagulants. Dental update
    Dinkova, Atanaska
    Daskalov, Hristo
    Drangov, Martin
    Dandarov, Yavor
    JOURNAL OF IMAB, 2022, 22 : 17 - 20
  • [35] Development of factor VIIa-TF complex inhibitors for the treatment of cardiovascular disease
    Young, Wendy B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [36] NOVEL BLEEDING PREDICTION MODEL IN ATRIAL FIBRILLATION PATIENTS ON NEW ORAL ANTICOAGULANTS.
    Gronich, N.
    Barnett-Griness, O.
    Stein, N.
    Saliba, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S22 - S23
  • [37] Discovery of potent neutral factor VIIa inhibitors
    Wurtz, Nicholas R.
    Parkhurst, Brandon L.
    Jiang, Wen
    DeLucca, Indawati
    Zhang, Xiaojun
    Cheney, Daniel
    Rendina, Alan
    Metzler, William
    Wei, Anzhi
    Luettgen, Joseph
    Wong, Pancras
    Seiffert, Dietmar
    Wexler, Ruth R.
    Priestley, E. Scott
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [38] Atropisomer Control in Macrocyclic Factor VIIa Inhibitors
    Glunz, Peter W.
    Mueller, Luciano
    Cheney, Daniel L.
    Ladziata, Vladimir
    Zou, Yan
    Wurtz, Nicholas R.
    Wei, Anzhi
    Wong, Pancras C.
    Wexler, Ruth R.
    Priestley, E. Scott
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 4007 - 4018
  • [39] Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors
    Shiraishi, Takuya
    Kadono, Shojiro
    Haramura, Masayuki
    Kodama, Hirofumi
    Ono, Yoshiyuki
    Iikura, Hitoshi
    Esaki, Tohru
    Koga, Takaki
    Hattori, Kunihiro
    Watanabe, Yoshiaki
    Sakamoto, Akihisa
    Yoshihashi, Kazutaka
    Kitazawa, Takehisa
    Esaki, Keiko
    Ohta, Masateru
    Sato, Haruhiko
    Kozono, Toshiro
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (01) : 38 - 44
  • [40] Factor VIIa inhibitors: Improved pharmacokinetic parameters
    Kolesnikov, A
    Rai, R
    Young, WB
    Mordent, J
    Liu, L
    Torkelson, S
    Shrader, WD
    Leahy, EM
    Hu, HY
    Gjerstad, E
    Janc, J
    Katz, BA
    Sprengeler, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2243 - 2246
12345